详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

COVID-19 infection with complicated fulminant myocarditis: a case report

文献详情

资源类型：

Pubmed体系：

作者：

单位： [1]Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. [2]Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Huazhong University of Science and Technology, Wuhan 430030, China.

出处：

DOI：

ISSN：

关键词： COVID-19 Fulminant myocarditis Myositis

摘要：

Herein, we report the case of a young female patient who suffered from myositis and heart failure due to fulminant myocarditis induced by the 2019 coronavirus disease (COVID-19). After receiving intra-aortic balloon pump (IABP) and immunomodulatory treatment, her vital signs gradually stabilized and the IABP was removed. Cardiac and muscle magnetic resonance imaging confirmed extensive myocardial and skeletal muscle edema. Though it is not uncommon for COVID-19 infection to be complicated by myocarditis and myositis, such serious muscle injury warrants clinical vigilance.Copyright © 2023 China Heart House.

基金：

语种：

PubmedID：

第一作者：

第一作者单位： [1]Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. [2]Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Huazhong University of Science and Technology, Wuhan 430030, China.

通讯作者：

通讯机构： [1]Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. [2]Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Huazhong University of Science and Technology, Wuhan 430030, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis [2]Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis. [3]Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis [4]NOVEL INFLAMMATORY-ASSOCIATED BIOMARKERS FOR FULMINANT MYOCARDITIS [5]Characteristics of Electrocardiogram Findings in Fulminant Myocarditis [6]Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis [7]SARS-CoV-2: a potential novel etiology of fulminant myocarditis [8]癫痫患者精神共患病与新型冠状病毒肺炎 [9]Clinical Assessment of New Treatment Regimen for Adult Fulminant Myocarditis [10]Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis